Lindbrook Capital LLC Trims Stock Holdings in iShares Biotechnology ETF (NASDAQ:IBB)

Lindbrook Capital LLC trimmed its holdings in iShares Biotechnology ETF (NASDAQ:IBB) by 14.3% during the 4th quarter, HoldingsChannel reports. The institutional investor owned 900 shares of the financial services provider’s stock after selling 150 shares during the period. Lindbrook Capital LLC’s holdings in iShares Biotechnology ETF were worth $119,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also recently modified their holdings of IBB. BNP Paribas Financial Markets raised its holdings in shares of iShares Biotechnology ETF by 29.3% in the third quarter. BNP Paribas Financial Markets now owns 2,380,229 shares of the financial services provider’s stock worth $346,561,000 after buying an additional 538,899 shares during the period. Raymond James Financial Inc. purchased a new stake in shares of iShares Biotechnology ETF in the fourth quarter worth approximately $55,010,000. Healthcare of Ontario Pension Plan Trust Fund raised its holdings in shares of iShares Biotechnology ETF by 32.9% in the third quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 663,000 shares of the financial services provider’s stock worth $96,533,000 after buying an additional 164,000 shares during the period. Aprio Wealth Management LLC purchased a new stake in shares of iShares Biotechnology ETF in the fourth quarter worth approximately $18,476,000. Finally, DRW Securities LLC purchased a new position in iShares Biotechnology ETF during the 3rd quarter worth $5,990,000. 62.45% of the stock is currently owned by hedge funds and other institutional investors.

iShares Biotechnology ETF Stock Up 0.5 %

IBB opened at $136.95 on Friday. The stock’s fifty day moving average is $136.01 and its two-hundred day moving average is $140.40. The company has a market capitalization of $6.47 billion, a P/E ratio of 24.52 and a beta of 0.84. iShares Biotechnology ETF has a 52 week low of $123.60 and a 52 week high of $150.57.

iShares Biotechnology ETF Cuts Dividend

The company also recently disclosed a dividend, which was paid on Friday, December 20th. Shareholders of record on Tuesday, December 17th were issued a dividend of $0.0624 per share. The ex-dividend date of this dividend was Tuesday, December 17th.

iShares Biotechnology ETF Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.